-
Je něco špatně v tomto záznamu ?
High frequency of dicentric chromosomes detected by multi-centromeric FISH in patients with acute myeloid leukemia and complex karyotype
I. Sarova, J. Brezinova, Z. Zemanova, S. Ransdorfova, K. Svobodova, S. Izakova, L. Pavlistova, L. Lizcova, A. Berkova, K. Skipalova, L. Hodanova, C. Salek, A. Jonasova, K. Michalova,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Perzistentní odkaz
https://www.medvik.cz/link/bmc19028504
- MeSH
- akutní myeloidní leukemie genetika MeSH
- analýza přežití MeSH
- centromera * MeSH
- chromozomální aberace * MeSH
- hybridizace in situ fluorescenční metody MeSH
- karyotyp * MeSH
- lidé středního věku MeSH
- lidé MeSH
- lidské chromozomy, pár 17 MeSH
- lidské chromozomy, pár 20 MeSH
- monozomie MeSH
- prognóza MeSH
- pruhování chromozomů MeSH
- senioři MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Dicentric chromosomes (DCs) are considered markers of cancer in various malignancies. However, they can be overlooked when conventional analysis or multicolor fluorescence in situ hybridization (mFISH) is used to detect complex karyotypes. We analyzed the karyotypes of 114 patients with acute myeloid leukemia (AML) and complex karyotypes and verified the presence of monosomies by FISH using multi-centromeric probes. Monosomy was detected in 63% of patients by G-banding/mFISH and confirmed in 55% of patients by centromeric FISH. FISH analysis indicated a high frequency of DCs that were previously considered monosomies. In some cases, it was apparent that the derivative monocentric chromosome was a primary DC. DCs were formed mostly by chromosomes 17 and 20. In conclusion, chromosome loss and unbalanced translocation suggest the presence of a hidden DC or its previous existence. DCs undergo several stabilizing changes and can induce other chromosomal aberrations and/or the formation of new DCs. This can result in the clonal evolution of abnormal cells, which is considered an independent prognostic marker of an unfavorable disease course and short survival.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028504
- 003
- CZ-PrNML
- 005
- 20241204100152.0
- 007
- ta
- 008
- 190813e20180319enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.leukres.2018.03.009 $2 doi
- 035 __
- $a (PubMed)29574397
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Sarova, Iveta $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague 2, Czech Republic; Center of Oncocytogenetics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University, U Nemocnice 2, 128 08, Prague 2, Czech Republic. Electronic address: iveta.sarova@uhkt.cz.
- 245 10
- $a High frequency of dicentric chromosomes detected by multi-centromeric FISH in patients with acute myeloid leukemia and complex karyotype / $c I. Sarova, J. Brezinova, Z. Zemanova, S. Ransdorfova, K. Svobodova, S. Izakova, L. Pavlistova, L. Lizcova, A. Berkova, K. Skipalova, L. Hodanova, C. Salek, A. Jonasova, K. Michalova,
- 520 9_
- $a Dicentric chromosomes (DCs) are considered markers of cancer in various malignancies. However, they can be overlooked when conventional analysis or multicolor fluorescence in situ hybridization (mFISH) is used to detect complex karyotypes. We analyzed the karyotypes of 114 patients with acute myeloid leukemia (AML) and complex karyotypes and verified the presence of monosomies by FISH using multi-centromeric probes. Monosomy was detected in 63% of patients by G-banding/mFISH and confirmed in 55% of patients by centromeric FISH. FISH analysis indicated a high frequency of DCs that were previously considered monosomies. In some cases, it was apparent that the derivative monocentric chromosome was a primary DC. DCs were formed mostly by chromosomes 17 and 20. In conclusion, chromosome loss and unbalanced translocation suggest the presence of a hidden DC or its previous existence. DCs undergo several stabilizing changes and can induce other chromosomal aberrations and/or the formation of new DCs. This can result in the clonal evolution of abnormal cells, which is considered an independent prognostic marker of an unfavorable disease course and short survival.
- 650 _2
- $a senioři $7 D000368
- 650 12
- $a centromera $7 D002503
- 650 12
- $a chromozomální aberace $7 D002869
- 650 _2
- $a pruhování chromozomů $7 D002871
- 650 _2
- $a lidské chromozomy, pár 17 $7 D002886
- 650 _2
- $a lidské chromozomy, pár 20 $7 D002890
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hybridizace in situ fluorescenční $x metody $7 D017404
- 650 12
- $a karyotyp $7 D059785
- 650 _2
- $a akutní myeloidní leukemie $x genetika $7 D015470
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a monozomie $7 D009006
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a analýza přežití $7 D016019
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Brezinova, Jana $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague 2, Czech Republic.
- 700 1_
- $a Zemanova, Zuzana $u Center of Oncocytogenetics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University, U Nemocnice 2, 128 08, Prague 2, Czech Republic.
- 700 1_
- $a Ransdorfova, Sarka $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague 2, Czech Republic.
- 700 1_
- $a Svobodová, Karla, $u Center of Oncocytogenetics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University, U Nemocnice 2, 128 08, Prague 2, Czech Republic. $d 1986- $7 xx0276416
- 700 1_
- $a Izakova, Silvia $u Center of Oncocytogenetics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University, U Nemocnice 2, 128 08, Prague 2, Czech Republic.
- 700 1_
- $a Pavlistova, Lenka $u Center of Oncocytogenetics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University, U Nemocnice 2, 128 08, Prague 2, Czech Republic.
- 700 1_
- $a Lizcova, Libuse $u Center of Oncocytogenetics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University, U Nemocnice 2, 128 08, Prague 2, Czech Republic.
- 700 1_
- $a Berková, Adéla $u Center of Oncocytogenetics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University, U Nemocnice 2, 128 08, Prague 2, Czech Republic. $7 xx0325890
- 700 1_
- $a Skipalova, Karolina $u Center of Oncocytogenetics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University, U Nemocnice 2, 128 08, Prague 2, Czech Republic.
- 700 1_
- $a Hodaňová, Lucie $u Center of Oncocytogenetics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University, U Nemocnice 2, 128 08, Prague 2, Czech Republic. $7 xx0276423
- 700 1_
- $a Salek, Cyril $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague 2, Czech Republic.
- 700 1_
- $a Jonasova, Anna $u 1st Department of Internal Medicine of General University Hospital and 1st Faculty of Medicine, Charles University, U Nemocnice 2, 128 08, Prague 2, Czech Republic.
- 700 1_
- $a Michalova, Kyra $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague 2, Czech Republic; Center of Oncocytogenetics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University, U Nemocnice 2, 128 08, Prague 2, Czech Republic.
- 773 0_
- $w MED00003141 $t Leukemia research $x 1873-5835 $g Roč. 68 (20180319), s. 85-89
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29574397 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20241204100147 $b ABA008
- 999 __
- $a ok $b bmc $g 1433653 $s 1066964
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 68 $c - $d 85-89 $e 20180319 $i 1873-5835 $m Leukemia research $n Leuk Res $x MED00003141
- LZP __
- $a Pubmed-20190813
